Interleukin-17 and interleukin-22 promote tumor progression in human nonmelanoma skin cancer

European Journal of Immunology

Volumn 45, Issue 3, 2015, Pages 922-931

  Nardinocchi, Lavinia ^a   Sonego, Giulio ^a   Passarelli, Francesca ^a   Avitabile, Simona ^a   Scarponi, Claudia ^a   Failla, Cristina Maria ^a   Simoni, Stefano ^a   Albanesi, Cristina ^a   Cavani, Andrea ^a  

^a LABORATORIO DI PATOLOGIA VASCOLARE   (Italy)

Author keywords

Cancer; Dermatology; IL 17; IL 22; T cells

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 22; INTERLEUKIN 6; INTERLEUKIN 8; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE B; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN; IL8 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; TUMOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BASAL CELL CARCINOMA; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NON MELANOMA SKIN CANCER; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SKIN BIOPSY; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; UPREGULATION; ANIMAL; CLINICAL TRIAL; FEMALE; IMMUNOLOGY; MALE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR; TUMOR CELL LINE; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, BASAL CELL; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; FEMALE; HUMANS; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKIN-8; INTERLEUKINS; MALE; MICE; MICE, NUDE; NEOPLASM PROTEINS; NF-KAPPA B; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR MICROENVIRONMENT;

EID: 84924455824     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201445052     Document Type: Article

References (48)

1. Ridky, T. W., Nonmelanoma skin cancer. J. Am. Acad. Dermatol. 2007. 57: 484-501.
2. Glogau, R. G., The risk of progression to invasive disease. J. Am. Acad. Dermatol. 2000. 42: 23-24.
3. Armstrong, B. K. and Kricker, A., The epidemiology of UV induced skin cancer. J. Photochem. Photobiol. B 2001. 63: 8-18.
4. Kim, R. H. and Armstrong, A. W., Nonmelanoma skin cancer. Dermatol. Clin. 2012. 30: 125-39, ix.
5. Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pages, C., Tosolini, M. et al., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 2006. 313: 1960-1964.
6. Leffers, N., Gooden, M. J., de Jong, R. A., Hoogeboom, B. N., ten Hoor, K. A., Hollema, H., Boezen, H. M. et al., Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer. Cancer Immunol. Immunother. 2009. 58: 449-459.
7. Galon, J., Pages, F., Marincola, F. M., Thurin, M., Trinchieri, G., Fox, B. A., Gajewski, T. F. et al., The immune score as a new possible approach for the classification of cancer. J. Transl. Med. 2012. 10: 1.
8. + T cells. J. Exp. Med. 2003. 197: 1017-1028.
9. Numasaki, M., Fukushi, J., Ono, M., Narula, S. K., Zavodny, P. J., Kudo, T., Robbins, P. D. et al., Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003. 101: 2620-2627.
10. Moussai, D., Mitsui, H., Pettersen, J. S., Pierson, K. C., Shah, K. R., Suarez-Farinas, M., Cardinale, I. R. et al., The human cutaneous squamous cell carcinoma microenvironment is characterized by increased lymphatic density and enhanced expression of macrophage-derived VEGF-C. J. Invest. Dermatol. 2011. 131: 229-236.
11. Vendramini-Costa, D. B. and Carvalho, J. E., Molecular link mechanisms between inflammation and cancer. Curr. Pharm. Des. 2012. 18: 3831-3852.
12. Kolls, J. K. and Linden, A., Interleukin-17 family members and inflammation. Immunity 2004. 21: 467-476.
13. Ouyang, W., Kolls, J. K. and Zheng, Y., The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008. 28: 454-467.
14. Spolski, R. and Leonard, W. J., Cytokine mediators of Th17 function. Eur. J. Immunol. 2009. 39: 658-661.
15. Martin-Orozco, N. and Dong, C., The IL-17/IL-23 axis of inflammation in cancer: friend or foe? Curr. Opin. Investig. Drugs 2009. 10: 543-549.
16. Wilke, C. M., Kryczek, I., Wei, S., Zhao, E., Wu, K., Wang, G. and Zou, W., Th17 cells in cancer: help or hindrance? Carcinogenesis 2011. 32: 643-649.
17. Maniati, E., Soper, R. and Hagemann, T., Up for Mischief? IL-17/Th17 in the tumour microenvironment. Oncogene 2010. 29: 5653-5662.
18. Zenewicz, L. A. and Flavell, R. A., Recent advances in IL-22 biology. Int. Immunol. 2011. 23: 159-163.
19. Pickert, G., Neufert, C., Leppkes, M., Zheng, Y., Wittkopf, N., Warntjen, M., Lehr, H. A. et al., STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J. Exp. Med. 2009. 206: 1465-1472.
20. Eyerich, S., Eyerich, K., Pennino, D., Carbone, T., Nasorri, F., Pallotta, S., Cianfarani, F. et al., Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J. Clin. Invest. 2009. 119: 3573-3585.
21. Duhen, T., Geiger, R., Jarrossay, D., Lanzavecchia, A. and Sallusto, F., Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat. Immunol. 2009. 10: 857-863.
22. Zenewicz, L. A., Yancopoulos, G. D., Valenzuela, D. M., Murphy, A. J., Karow, M. and Flavell, R. A., Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 2007. 27: 647-659.
23. Boniface, K., Bernard, F. X., Garcia, M., Gurney, A. L., Lecron, J. C. and Morel, F., IL-22 inhibits epidermal differentiation and induces proinflammatory gene expression and migration of human keratinocytes. J. Immunol. 2005. 174: 3695-3702.
24. Sestito, R., Madonna, S., Scarponi, C., Cianfarani, F., Failla, C. M., Cavani, A., Girolomoni, G. et al., STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J. 2011. 25: 916-927.
25. Zhang, W., Chen, Y., Wei, H., Zheng, C., Sun, R., Zhang, J. and Tian, Z., Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clin. Cancer. Res. 2008. 14: 6432-6439.
26. Jiang, R., Wang, H., Deng, L., Hou, J., Shi, R., Yao, M., Gao, Y. et al, IL-22 is related to development of human colon cancer by activation of STAT3. BMC Cancer 2013. 13: 59.
27. Naher, L., Kiyoshima, T., Kobayashi, I., Wada, H., Nagata, K., Fujiwara, H., Ookuma, Y. F. et al., STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma. Int. J. Oncol. 2012. 41: 1577-1586.
28. Albanesi, C., Cavani, A. and Girolomoni, G., IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha. J. Immunol. 1999. 162: 494-502.
29. Pennino, D., Eyerich, K., Scarponi, C., Carbone, T., Eyerich, S., Nasorri, F., Garcovich, S. et al., IL-17 amplifies human contact hypersensitivity by licensing hapten nonspecific Th1 cells to kill autologous keratinocytes. J. Immunol. 2010. 184: 4880-4888.
30. Hartman, Z. C., Poage, G. M., den Hollander, P., Tsimelzon, A., Hill, J., Panupinthu, N., Zhang, Y. et al., Growth of triple-negative breast cancer cells relies upon coordinate autocrine expression of the proinflammatory cytokines IL-6 and IL-8. Cancer. Res. 2013. 73: 3470-3480.
31. Gu, F. M., Li, Q. L., Gao, Q., Jiang, J. H., Zhu, K., Huang, X. Y., Pan, J. F. et al., IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol. Cancer. 2011. 10: 150.
32. Desai, S., Laskar, S. and Pandey, B. N., Autocrine IL-8 and VEGF mediate epithelial-mesenchymal transition and invasiveness via p38/JNK-ATF-2 signalling in A549 lung cancer cells. Cell. Signal. 2013. 25: 1780-1791.
33. Mitra, A., Raychaudhuri, S. K. and Raychaudhuri, S. P., IL-22 induced cell proliferation is regulated by PI3K/Akt/mTOR signaling cascade. Cytokine 2012. 60: 38-42.
34. Karin, M. and Greten, F. R., NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol. 2005. 5: 749-759.
35. Joyce, J. A. and Pollard, J. W., Microenvironmental regulation of metastasis. Nat. Rev. Cancer. 2009. 9: 239-252.
36. Mantovani, A., Allavena, P., Sica, A. and Balkwill, F., Cancer-related inflammation. Nature 2008. 454: 436-444.
37. Yu, H., Kortylewski, M. and Pardoll, D., Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment. Nat. Rev. Immunol. 2007. 7: 41-51.
38. Gu, F. M., Li, Q. L., Gao, Q., Jiang, J. H., Zhu, K., Huang, X. Y., Pan, J. F. et al., IL-17 induces AKT-dependent IL-6/JAK2/STAT3 activation and tumor progression in hepatocellular carcinoma. Mol. Cancer. 2011. 10: 150.
39. Jiang, R., Tan, Z., Deng, L., Chen, Y., Xia, Y., Gao, Y., Wang, X. et al., Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 2011. 54: 900-909.
40. Steiner, G. E., Newman, M. E., Paikl, D., Stix, U., Memaran-Dagda, N., Lee, C. and Marberger, M. J., Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 2003. 56: 171-182.
41. Miyahara, Y., Odunsi, K., Chen, W., Peng, G., Matsuzaki, J. and Wang, R. F., Generation and regulation of human CD4+ IL-17-producing T cells in ovarian cancer. Proc. Natl. Acad. Sci. USA 2008. 105: 15505-15510.
42. + T cells in hepatocellular carcinoma patients. J. Immunol. 2010. 185: 1544-1549.
43. Numasaki, M., Fukushi, J., Ono, M., Narula, S. K., Zavodny, P. J., Kudo, T., Robbins, P. D. et al., Interleukin-17 promotes angiogenesis and tumor growth. Blood 2003. 101: 2620-2627.
44. Wang, L., Yi, T., Zhang, W., Pardoll, D. M. and Yu, H., IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer Res. 2010. 70: 10112-10120.
45. Zhuang, Y., Peng, L. S., Zhao, Y. L., Shi, Y., Mao, X. H., Chen, W., Pang, K. C. et al., CD8(+) T cells that produce interleukin-17 regulate myeloid-derived suppressor cells and are associated with survival time of patients with gastric cancer. Gastroenterology 2012. 143: 951-62.e8.
46. Tartour, E., Fossiez, F., Joyeux, I., Galinha, A., Gey, A., Claret, E., Sastre-Garau, X. et al., Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice. Cancer Res. 1999. 59: 3698-704.
47. Bian, G. and Zhao, W. Y., IL-17, an important prognostic factor and potential therapeutic target for breast cancer? Eur. J. Immunol. 2014. 44: 604-605.
48. Benevides, L., Cardoso, C. R., Tiezzi, D. G., Marana, H. R., Andrade, J. M. and Silva, J. S., Enrichment of regulatory T cells in invasive breast tumor correlates with the upregulation of IL-17A expression and invasiveness of the tumor. Eur. J. Immunol. 2013. 43: 1518-1528.